BioCentury
ARTICLE | Clinical News

TG1050: Phase I/Ib ongoing

August 1, 2016 7:00 AM UTC

Transgene said a safety review committee recommended continuation of a double-blind, placebo-controlled, international Phase I/Ib trial evaluating single injections and 3 once-weekly injections of TG1...